Radionetics Oncology
Yael Cohen-Arazi is a seasoned professional with extensive experience in clinical operations and research management. Currently serving as the Senior Manager of Clinical Operations at Radionetics Oncology since September 2024, Yael has previously held key roles such as Clinical Operations Manager at Nitto BioPharma and Project Manager at Medidata Solutions. With a strong foundation in clinical research, Yael has also managed projects at UCSD Moores Cancer Center, focusing on melanoma and thyroid research, as well as overseeing Palliative Care Clinical Research Operations. In addition to a career in clinical settings, Yael has been a Certified Pilates Instructor since February 2014, teaching in a fully equipped studio. Educational qualifications include a B.Sc in Nutrition from The Hebrew University of Jerusalem, with further training and certifications from various educational institutions.
This person is not in the org chart
This person is not in any teams
Radionetics Oncology
Radionetics Oncology is a pharmaceutical company focused on the discovery and development of novel radiotherapeutics for the treatment of a wide range of oncology indications. The company’s platform technology uses nonpeptide, small molecule targeting to deliver therapeutic radioisotopes to a broad range of cancers by binding selectively to peptide receptors that are selectively expressed on these tumors. This nonpeptide technology addresses many of the significant challenges currently facing peptide and protein targeted radiotherapeutics, particularly in the realm of optimizing drug-like characteristics and manufacturing. The company is rapidly advancing a pipeline of drug candidates to treat a broad range of cancers and is conducting additional drug discovery efforts to identify drug candidates for additional receptor targets in collaboration with Crinetics Pharmaceuticals.